Gong Z, Xue L, Vlantis A, van Hasselt C, Chan J, Fang J, et al. Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2. J Endocrinol Invest. 2023;: pubmed publisher

Xu C, Gao Q, Wu Z, Lou W, Li X, Wang M, et al. Combined HASPIN and mTOR inhibition is synergistic against KRAS-driven carcinomas. Transl Oncol. 2022;26:101540 pubmed publisher

Alhayyani S, McLeod L, West A, Balic J, Hodges C, Yu L, et al. Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer. Oncogene. 2021;: pubmed publisher

Castellan M, Guarnieri A, Fujimura A, Zanconato F, Battilana G, Panciera T, et al. Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in Glioblastoma. Nat Cancer. 2021;2:174-188 pubmed publisher

Ye H, Liu Y, Wu K, Luo H, Cui L. AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer. Cell Commun Signal. 2020;18:115 pubmed publisher

Kumazaki M, Shimomura I, Kiyono T, Ochiya T, Yamamoto Y. Cell-type specific tumorigenesis with Ras oncogenes in human lung epithelial cells. Biochem Biophys Res Commun. 2020;525:483-490 pubmed publisher

Ogawa F, Walters M, Shafquat A, O Beirne S, Kaner R, Mezey J, et al. Role of KRAS in regulating normal human airway basal cell differentiation. Respir Res. 2019;20:181 pubmed publisher

Liu H, Sun M, Liu Z, Kong C, Kong W, Ye J, et al. KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs. J Control Release. 2019;296:40-53 pubmed publisher

Bennett Saidu N, Bretagne M, Mansuet A, Just P, Leroy K, Cerles O, et al. Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells. Oncotarget. 2018;9:9088-9099 pubmed publisher

Mulcahy Levy J, Zahedi S, Griesinger A, Morin A, Davies K, Aisner D, et al. Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors. elife. 2017;6: pubmed publisher

Weaver R, Limzerwala J, Naylor R, Jeganathan K, Baker D, van Deursen J. BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer. elife. 2016;5: pubmed publisher

Wiersma V, de Bruyn M, Wei Y, van Ginkel R, Hirashima M, Niki T, et al. The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux. Autophagy. 2015;11:1373-88 pubmed publisher

Lampson B, Pershing N, Prinz J, Lacsina J, Marzluff W, Nicchitta C, et al. Rare codons regulate KRas oncogenesis. Curr Biol. 2013;23:70-5 pubmed publisher